| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |